Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion type Assertion NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_head.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion description "[KRAS mutations were detected in 34% of carcinomas, 31% of sporadic adenomas, 9% of FAP adenomas, and no hyperplastic polyps.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_provenance.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion evidence source_evidence_literature NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_provenance.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion SIO_000772 12438234 NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_provenance.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion wasDerivedFrom befree-20140225 NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_provenance.
- NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_assertion wasGeneratedBy ECO_0000203 NP582844.RAwlOalPoJrVF8qK8JF3y1hHFN79b55f_1JDfC0_fp1LU130_provenance.